Use of Transient Elastogaphy to Assess Diaphragm Function in Mechanically Ventilated Patients
Elasto-ICU
Evaluation of Diaphragmatic Function in Mechanically Ventilated Patients With Transient Shear Wave Elastography
2 other identifiers
interventional
30
1 country
1
Brief Summary
Mechanical ventilation is a life-saving treatment that can be associated with diaphragm dysfunction, a potentially deleterious acquired disability. It may be the consequence of disuse - under mechanical ventilation, respiratory muscles are unloaded - or the consequence of muscle overuse because of insufficient unloading. Evaluating diaphragm function is therefore crucial to optimally tailor the ventilator assistance. Measurement of transdiaphragmatic pressure (Pdi) is the reference method to assess diaphragm function but it invasiveness hinders the generalization of its use. Previous studies have reported that ultrasound can quantify diaphragm thickening and that diaphragm thickening fraction (TFdi) is a good marker of diaphragm function. Since diaphragm becomes stiffer when it contracts, the investigators aim at exploring whether the measurement of diaphragm stiffness by transient shear wave elastography would improve the evaluation of diaphragm function with ultrasound. Therefore, the objectives of the study are to evaluate the performance of transient shear wave elastography applied to the diaphragm to estimate Pdi in mechanically ventilated patients as compared to TFdi and to correlate the changes in elastography derived indices, in TFdi and in Pdi into different ventilatory conditions and during a spontaneous breathing trial. Pdi will be obtained using catheters positioned in patients' stomachs and esophagus and diaphragm stiffness will be assessed by measuring the shear modulus of the diaphragm with a dedicated ultrasound machine (Aixplorer, Ultrasonic). TFdi will be also measured as previously reported. Pdi, TFdi and shear modulus will be measured at the end of each four following 10 minutes-conditions: 1) baseline with initial ventilator settings (set by the physician in charge of patient); 2) 25%-increase in pressure support and initial PEEP; 3) 25%-decrease in pressure support and initial PEEP and 4) initial level of pressure support and ZEEP. Finally, the same measurements will be done at the beginning of a 30 minutes spontaneous breathing trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
February 6, 2019
CompletedStudy Start
First participant enrolled
February 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2020
CompletedMarch 1, 2021
February 1, 2021
1 day
January 11, 2019
February 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in transdiaphragmatic pressure
Reference method to assess diaphragm function computed as the difference between esophageal pressure and gastric pressure
Through patient participation, an average of 1 day
Secondary Outcomes (3)
Change in diaphragm thickness and thickening as expressed by the thickening fraction (ratio of the difference between inspiratory and expiratory thickness over expiratory thickness).
Through patient participation, an average of 1 day
Change in diaphragm stiffness
Through patient participation, an average of 1 day
Success or failure at the spontaneous breathing trial
Through patient participation, an average of 1 day
Study Arms (1)
Ventilator liberating trial
EXPERIMENTALThe diaphragmatic function of patients undergoing a ventilator liberating trial will be determined with transient shear wave elastography.
Interventions
Ultrasound technology to assess tissue stiffness
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old
- Intubation and mechanical ventilation since 24 hours
- Failure to a first ventilator liberating trial
- nasogastric feeding tube in place
- readiness criteria to undertake a ventilator liberating trial (Boles et al. ERJ 2007)
- patient written consent or next of kin written consent in case of physical inability of the patient to sign the consent form
- french social Health Service registration
You may not qualify if:
- pregnancy
- protective administrative control
- patient's refusal
- contra indications to the insertion of esophageal and gastric balloons
- allergy to topical anesthetic
- impossible weaning (full dependance to mechanical ventilation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Pitié-Salpétrière
Paris, 75013, France
Related Publications (1)
Fosse Q, Poulard T, Nierat MC, Virolle S, Morawiec E, Hogrel JY, Similowski T, Demoule A, Gennisson JL, Bachasson D, Dres M. Ultrasound shear wave elastography for assessing diaphragm function in mechanically ventilated patients: a breath-by-breath analysis. Crit Care. 2020 Nov 27;24(1):669. doi: 10.1186/s13054-020-03338-y.
PMID: 33246478DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Martin DRES, MD, PhD
Assistance Publique Hoptiaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2019
First Posted
February 6, 2019
Study Start
February 14, 2019
Primary Completion
February 15, 2019
Study Completion
July 9, 2020
Last Updated
March 1, 2021
Record last verified: 2021-02